# OnCo record idea-ctdna-guided-adjuvant-melanoma (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-ctdna-guided-adjuvant-melanoma/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-ctdna-guided-adjuvant-melanoma" ;
  schema:name "ctDNA-guided adjuvant therapy in stage II-III melanoma"@en ;
  schema:description "Most stage II patients never relapse, yet all are offered a year of immunotherapy. Use a blood test to treat only those with detectable residual disease."@en ;
  schema:url <https://onco.cc/ideas/idea-ctdna-guided-adjuvant-melanoma/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03553836>, <https://clinicaltrials.gov/study/NCT04660344> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:terms <https://onco.cc/terms/mrd/> ;
  onco:trials <https://onco.cc/trials/keynote-716/>, <https://onco.cc/trials/imvigor011/> .